Drug giant Sanofi-Aventis offers $18.5 billion for Genzyme
May 9, 2011 by weddingdress
Drug giant Sanofi-Aventis offers $18.5 billion for Genzyme
French drug giant Sanofi-Aventis SA on Sunday publicly launched its $18.5 billion cash bid for American biotech firm Genzyme Corp. — a move that follows months of rumored interest and failed attempts to bring Genzyme’s management to the table.
Under terms of the proposed acquisition, Genzyme shareholders would receive $69 per share,
where can i buy christian louboutin shoes, representing a 38 percent premium over Genzyme’s closing stock price of $49.86 on July 1. That’s the day before speculation began to swirl that Sanofi was looking to buy an American drugmaker, possibly Genzyme, in a bid to help replace revenue being lost to worsening generic competition. Since then, the French company unexpectedly was faced with generic competition for its blockbuster injected anticlotting drug, Lovenox,Shop the latest juicy couture purses handpicked by a global community of independent trendsetters and stylists. which brought Sanofi $3.Handbag Styles Ladies will enjoy browsing and choosing a handbag style from clutch purse, Shoulder, Bow, Boston, Bowling, Moon, Doctor, Hobo, De Grade, Pouchette, Bauletto, Vernice and Chevron.9 billion last year.
Sanofi-Aventis is taking the bid public after what it calls “several unsuccessful attempts” to engage Genzyme’s management in talks. While it prefers to work with the board instead of taking the offer directly to shareholders, CEO Christopher A. Viehbacher said on a conference call Sunday that “we are also prepared to consider all alternatives to complete this transaction.”
“Sanofi-aventis believes strongly in this acquisition and its strategic and financial benefits,
christian louboutin madame butterfly,” Viehbacher said. “We remain focused on entering into constructive discussions with Genzyme in order to complete this transaction.”
The bid for Cambridge, Mass.If you want to buy GHD hair straighteners,you can buy them in theGUCCI CAPS store online, you must can save more money and buy good product.-based Genzyme is in line with Sanofi’s strategy to seek future growth by diversifying. Since Viehbacher defected from rival GlaxoSmithKline PLC and took the top spot at Sanofi-Aventis in December 2008, the company has completed about 50 generally small- to mid-sized acquisitions and partnerships. Analysts have said buying Genzyme would boost Sanofi-Aventis’ earnings,You will find cheap miu miu bag imitations,
christian louboutin helmut! Indeed, our quality and service chart is not only present and enforced at all levels. help it rebuild its drug development pipeline and speed up its transition to more sustainable growth, the analysts said.
By 2013, Sanofi-Aventis aims to be less dependent on aging patent-protected blockbusters like Plavix and Lovenox, as the company leans more heavily on six markets where it sees the most growth: vaccines, diabetes products,What is uncommon, Recycle Bag are becoming more popular than ever, in the world of reusable bags is their use in everyday life. over-the-counter medicines, new treatments and emerging markets as well as the Japanese market.